Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience-Reference-Cited by-同舟云学术

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

Published:2023-10 Issue:5 Volume:21 Page:584-593
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Bakaloudi Dimitra Rafailia^ORCID,Talukder Rafee^ORCID,Lin Genevieve Ihsiu,Makrakis Dimitrios^ORCID,Diamantopoulos Leonidas N.,Tripathi Nishita^ORCID,Agarwal Neeraj^ORCID,Zakopoulou Roubini^ORCID,Bamias Aristotelis^ORCID,Brown Jason R.^ORCID,Pinato David J.,Korolewicz James^ORCID,Jindal Tanya^ORCID,Koshkin Vadim S.^ORCID,Murgić Jure^ORCID,Miletić Marija^ORCID,Frobe Ana^ORCID,Johnson Jeffrey,Zakharia Yousef,Drakaki Alexandra,Rodriguez-Vida Alejo^ORCID,Rey-Cárdenas Macarena,Castellano Daniel,Buznego Lucia Alonso^ORCID,Duran Ignacio^ORCID,Carballeira Clara Castro^ORCID,Barrera Rafael Morales^ORCID,Marmorejo David,McKay Rana R.,Stewart Tyler,Gupta Shilpa,Ruplin Andrew Thomas^ORCID,Yu Evan Y.,Khaki Ali R.^ORCID,Grivas Petros^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference37 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Survival rates and health care costs for patients with advanced bladder cancer treated and untreated with chemotherapy;Flannery;Clin Genitourin Cancer,2018

3. Bladder Cancer, Version 5.2017, NCCN clinical practice guidelines in oncology;Spiess;J Natl Compr Canc Netw,2017

4. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma;Powles;N Engl J Med,2020

5. Avelumab first-line maintenance for advanced urothelial carcinoma: results from the JAVELIN Bladder 100 trial after ≥2 years of follow-up;Powles;J Clin Oncol,2023

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor;Clinical Genitourinary Cancer;2024-12

2. READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma;ESMO Real World Data and Digital Oncology;2024-09

3. A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape;Advances in Therapy;2024-07-18

4. Experience and Prognostic Analysis with Avelumab Switch Maintenance Treatment in Metastatic Urothelial Carcinoma;Oncology;2024-07-17

5. Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program;Frontiers in Oncology;2024-06-03